Human Immunodeficiency Virus (HIV) is a lentivirus that progressively attacks the body's immune system, specifically targeting CD4+ T lymphocytes. Left unchecked, the virus depletes these critical immune cells, leaving the body vulnerable to opportunistic infections and cancers. Acquired Immunodeficiency Syndrome (AIDS) represents the most advanced stage of this viral infection. A person reaches this clinical milestone when their CD4 count drops below 200 cells per microliter of blood or when they develop one or more specific opportunistic illnesses. Understanding this distinction helps healthcare providers explain to patients that living with HIV does not automatically mean having AIDS.
The pathogenesis of HIV relies on viral entry, reverse transcription, integration, and replication within host cells.
HIV spreads primarily through direct contact with specific body fluids from an infected person, including blood, semen, pre-seminal fluid, rectal fluids, vaginal fluids, and breast milk. In sub-Saharan Africa, heterosexual intercourse remains the leading driver of new infections. Mother-to-child transmission during pregnancy, labor, delivery, or breastfeeding is another critical pathway. Occupational exposure through needle-stick injuries poses a continuous risk for healthcare workers. Casual contact, sharing utensils, hugging, or insect bites do not transmit the virus.
The natural history of untreated HIV infection unfolds across three distinct clinical phases:
Clinical signs of HIV vary based on the infection stage and immune status. During the acute phase, individuals frequently report fever, fatigue, lymphadenopathy, pharyngitis, and myalgia. As the immune system deteriorates into advanced disease, opportunistic conditions emerge. Oral hairy leukoplakia, persistent generalized lymphadenopathy, chronic diarrhea, and unintended weight loss indicate failing cellular immunity. Advanced AIDS frequently presents with severe opportunistic infections such as Pneumocystis jirovecii pneumonia, cryptococcal meningitis, and Kaposi sarcoma.
Accurate detection of HIV relies on specific blood tests that identify antibodies, antigens, or viral RNA. Fourth-generation screening assays detect both HIV antibodies and the p24 antigen, allowing for earlier detection than older antibody-only tests. Rapid diagnostic tests provide results within minutes using capillary whole blood or oral fluid. Confirmatory testing, such as Western blot or viral load assays, validates initial positive screenings. Viral load testing measures the quantity of viral RNA in plasma, serving as the gold standard for monitoring treatment efficacy.
Antiretroviral therapy involves combining three or more drugs from different classes to suppress HIV replication, preserve immune function, and prevent transmission. Modern regimens are well-tolerated, single-pill options taken once daily. Treatment success aims to achieve an undetectable viral load, which protects the patient's health and eliminates sexual transmission risk, summarized as Undetectable equals Untransmittable (U=U). Lifelong adherence is mandatory, as treatment interruptions allow viral rebound and drug resistance.
Nursing care for patients with HIV encompasses clinical management, counseling, and preventive education. Nurses promote prevention strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) for high-risk individuals and exposed workers. Essential nursing interventions include assessing medication adherence, managing side effects, screening for opportunistic infections, and providing psychosocial support to reduce stigma. Confidential counseling and education empower clients to protect themselves and their sexual partners.